a new oral bisphosphonate for osteoporosis called Boniva (ibandronate)

In 2005 you'll see a new oral bisphosphonate for osteoporosis called Boniva (ibandronate).

It'll be the first one approved for dosing once a MONTH.

Bisphosphonates are good candidates for intermittent dosing. They can remain active in the bone for several weeks or longer.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote